Abbott Laboratories on Monday announced the €4.5bn ($6.6bn) acquisition of Solvay’s pharmaceutical company, bringing a five-month takeover battle to an end and highlighting continued consolidation in the industry.

The US drugmaker beat UCB of Belgium and Nycomed of Switzerland to buy the division.